Proxy Votes Now

Home › Funds › T. Rowe Price › T. Rowe Price Integrated U.S. Small-Mid Cap Core Equity Fund

T. Rowe Price Integrated U.S. Small-Mid Cap Core Equity Fund (TQSAX) proxy voting record 2025-2026

Fund family: T. Rowe Price · Filed by T. Rowe Price Integrated Equity Funds, Inc. (CIK 1038469) · SEC series S000052904

Share classes and tickers: TQSAX (C000166440), TQSIX (C000166441), TQSMX (C000166439)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 3,192 with, 20 against, 0 abstentions (not counted as with management); 1 items carried no recommendation. Shareholder proposals: 1 FOR, 19 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with T. Rowe Price as a whole

The same two figures as T. Rowe Price’s manager page (244,024 ballot items across 112 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsT. Rowe PriceItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)92.3%3,11593.7%208,710
Backed environmental and social shareholder proposals at US companiesn/a22.6%3,333

Where this fund voted differently from most T. Rowe Price funds

Each ballot item this fund voted is set against the votes of the other T. Rowe Price funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most T. Rowe Price funds on 35 items (1.2% of the 3,006 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost T. Rowe Price fundsMgmtResult
Birkenstock Holding Plc2026-04-29Amend Articles of AssociationForAGAINST — 11 of 14 T. Rowe Price fundsFor—
Birkenstock Holding Plc2026-04-29Elect Director Ruth KennedyForAGAINST — 11 of 14 T. Rowe Price fundsFor—
Cytokinetics, Incorporated2026-05-272 wordings Election of Class I Directors for terms expiring in 2029: Edward M. Kaye, M.D.WithholdFOR — 15 of 22 T. Rowe Price fundsAgainstPassed (calculated), 97.0% support
Service Corporation International2026-05-06Election of Directors: Marcus A. WattsForAGAINST — 12 of 18 T. Rowe Price fundsForFailed (calculated), 43.5% support
Service Corporation International2026-05-06To approve the 2026 Equity Incentive Plan.AgainstFOR — 12 of 18 T. Rowe Price fundsAgainstApproved, 78.1% support
Element Solutions Inc2026-05-04Election of Directors: E. Stanley O'NealForAGAINST — 7 of 10 T. Rowe Price fundsForPassed (calculated), 94.2% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Abid RizviAgainstFOR — 9 of 14 T. Rowe Price fundsAgainstPassed (calculated), 97.8% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Alissa AhlmanAgainstFOR — 9 of 14 T. Rowe Price fundsAgainstPassed (calculated), 97.8% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Mary BaglivoAgainstFOR — 9 of 14 T. Rowe Price fundsAgainstPassed (calculated), 97.8% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Richard ZanninoAgainstFOR — 9 of 14 T. Rowe Price fundsAgainstPassed (calculated), 95.8% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Robert FischAgainstFOR — 9 of 14 T. Rowe Price fundsAgainstPassed (calculated), 97.3% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Stanley FleishmanAgainstFOR — 9 of 14 T. Rowe Price fundsAgainstPassed (calculated), 90.7% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Stephen WhiteAgainstFOR — 9 of 14 T. Rowe Price fundsAgainstPassed (calculated), 97.5% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Thomas HendricksonAgainstFOR — 9 of 14 T. Rowe Price fundsAgainstPassed (calculated), 97.0% support
Element Solutions Inc2026-05-04Advisory vote to approve the Company's 2025 executive compensationAgainstFOR — 8 of 13 T. Rowe Price fundsAgainstFailed (calculated), 41.4% support
Dutch Bros Inc.2026-05-13Election of Directors: Todd PenegorForAGAINST — 10 of 17 T. Rowe Price fundsForElected, 91.7% support
Dutch Bros Inc.2026-05-13Election of Directors: Travis BoersmaForAGAINST — 10 of 17 T. Rowe Price fundsForElected, 95.6% support
Almonty Industries Inc.2026-06-09Elect Director Andrew FrazerForAGAINST — 9 of 15 T. Rowe Price fundsFor—
Almonty Industries Inc.2026-06-09Elect Director Daniel D'AmatoForAGAINST — 9 of 15 T. Rowe Price fundsFor—
Almonty Industries Inc.2026-06-09Elect Director David HanickForAGAINST — 9 of 15 T. Rowe Price fundsFor—
Almonty Industries Inc.2026-06-09Elect Director Lewis BlackForAGAINST — 9 of 15 T. Rowe Price fundsFor—
Almonty Industries Inc.2026-06-09Elect Director Mark TrachukForAGAINST — 9 of 15 T. Rowe Price fundsFor—
Urban Outfitters, Inc.2026-06-03Election of Directors: Amin N. MarediaAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 98.7% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Edward N. AntoianAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 97.6% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Harry S. Cherken, Jr.AgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 98.4% support
Show all 35
Items 26 to 35.
CompanyMeetingItemThis fundMost T. Rowe Price fundsMgmtResult
Urban Outfitters, Inc.2026-06-03Election of Directors: John C. MullikenAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 97.7% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Kelly CampbellAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 99.3% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Mary C. EganAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 98.7% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Todd R. MorgenfeldAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 99.1% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Wesley S. McDonaldAgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 98.3% support
MapLight Therapeutics, Inc.2026-06-23To elect the three Class I Director nominees named in the Proxy Statement to serve until the 2029 annual meeting of our stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Martin BablerForWITHHOLD — 8 of 14 T. Rowe Price fundsFor—
Xenon Pharmaceuticals Inc.2026-06-02To approve the Corporation's 2026 Equity Incentive Plan;AgainstFOR — 7 of 12 T. Rowe Price fundsAgainstApproved, 68.0% support
Kodiak Sciences Inc.2026-06-02Elect three Class II directors nominated by our board and named in this proxy statement: Charles A. BancroftForWITHHOLD — 8 of 15 T. Rowe Price fundsForElected, 78.7% support
Denali Therapeutics Inc.2026-06-03ELECTION OF DIRECTORS: David Schenkein, M.D.ForWITHHOLD — 8 of 15 T. Rowe Price fundsForElected, 73.5% support
Denali Therapeutics Inc.2026-06-03ELECTION OF DIRECTORS: Jennifer CookForWITHHOLD — 8 of 15 T. Rowe Price fundsForElected, 60.9% support

Download all 35 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 90.8% of this fund’s 3,212 such votes could be given a sector; the other 297 (9.2%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Consumer Discretionary58540.7%
Health Care52740.8%
Industrials52671.3%
Finance44720.4%
Technology32620.6%
Real Estate24000.0%
Energy10100.0%
Utilities7400.0%
Basic Materials2700.0%
Miscellaneous2600.0%
Consumer Staples2500.0%
Telecommunications1100.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections2,2890
Audit-related3450
Say-on-Pay3350
Compensation1081
Corporate Governance8317
Capital Structure480
Extraordinary Transactions200
Shareholder Rights and Defenses100
Other Social Issues21
Diversity, Equity, and Inclusion11

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Tenet Healthcare CorporationMay 27, 2026$19M140
Permian Resources CorporationMay 19, 2026$14M140
Reliance, Inc.May 20, 2026$14M121
Viatris Inc.May 15, 2026$13M150
East West Bancorp, Inc.May 18, 2026$13M150
BrightSpring Health Services, Inc.May 21, 2026$12M50
Charles River Laboratories International, Inc.May 5, 2026$12M150
Encompass Health CorporationMay 7, 2026$11M120

Notable votes against management

MeetingCompanyProposalFundMgmt
May 20, 2026Reliance, Inc.To consider a stockholder proposal requiring any director who fails to receive a majority vote to leave the board of directors within nine months. Shareholder proposalAgainstFor
May 7, 2026Corpay, Inc.Shareholder proposal regarding an independent Board Chair requirement, if properly presented at the meeting. Shareholder proposalAgainstFor
May 11, 2026MKS Inc.A shareholder proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 10%, if properly presented at the meeting. Shareholder proposalAgainstFor
May 20, 2026Quest Diagnostics IncorporatedStockholder proposal regarding an independent board chairman, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
January 22, 2026Jabil Inc.Vote on a stockholder proposal requesting stockholder right to act by written consent. Shareholder proposalAgainstFor
May 6, 2026Entegris, Inc.Stockholder Proposal: Providing stockholders the right to call special meetings of stockholders. Shareholder proposalAgainstFor
April 28, 2026Revvity, Inc.To approve the shareholder proposal regarding Executives to Retain Significant Stock. Shareholder proposalAgainstFor
May 21, 2026Assurant, Inc.Stockholder proposal regarding action by written consent. Shareholder proposalAgainstFor
April 30, 2026Global Payments Inc.Shareholder proposal regarding shareholder right to act by written consent. Shareholder proposalAgainstFor
May 5, 2026Oshkosh CorporationTo vote on a shareholder proposal on the subject of directors who fail to obtain a majority vote. Shareholder proposalAgainstFor
April 24, 2026Stanley Black & Decker, Inc.To consider and vote on a shareholder proposal requesting an independent Board Chairman. Shareholder proposalAgainstFor
May 15, 2026Medpace Holdings, Inc.Stockholder proposal regarding giving shareholders an ability to call for a special shareholder meeting, if properly presented at the meeting. Shareholder proposalAgainstFor

Search this fund’s votes by company

3,242 ballot items at 350 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, T. Rowe Price Integrated U.S. Small-Mid Cap Core Equity Fund (TQSAX) voted at 350 shareholder meetings of 344 companies, on 3,242 ballot items in all. Where management made a recommendation, the fund followed it on 99.4% of the items and voted against it 20 times. Its most frequent area of disagreement was corporate governance (17 of its votes against management). It voted on 20 shareholder proposals. It voted FOR the board's own proposals less often than T. Rowe Price's funds as a whole (92.3% against 93.7%). It voted differently from most T. Rowe Price funds on 35 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of T. Rowe Price’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.